Dyslipidemia in chronic kidney disease: pathogenesis and intervention.
作者： Grzegorz Piecha , Marcin Adamczak , Eberhard Ritz
DOI: 10.20452/PAMW.745
关键词:
摘要: Dyslipidemia is a known cardiovascular risk factor in subjects without kidney disease. In patients with disease, however, the relation of dyslipidemia to confounded and underlying pathomechanisms are complex. Statins have proven be highly effective initial stages chronic disease (CKD). Definite evidence from prospective controlled trials hemodialyzed (diabetic) transplanted not available. Although no significant impact on primary composite endpoint was observed, effects secondary endpoints were noted. our opinion, view excessive statins should administered advanced CKD as well.
sci-hub.st 参考文章(47)
Stephen L. Seliger, Noel S. Weiss, Daniel L. Gillen, Bryan Kestenbaum, Adrianne Ball, Donald J. Sherrard, Catherine O. Stehman-Breen, HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney International. ,vol. 61, pp. 297- 304 ,(2002) , 10.1046/J.1523-1755.2002.00109.X
Sohvi Hörkkö, Markku J. Savolainen, Kari Kervinen, Y. Antero Kesäniemi, Carbamylation-induced alterations in low-density lipoprotein metabolism Kidney International. ,vol. 41, pp. 1175- 1181 ,(1992) , 10.1038/KI.1992.179
David JP Barker, Susan P Bagby, Mark A Hanson, Mechanisms of Disease: in utero programming in the pathogenesis of hypertension Nature Clinical Practice Nephrology. ,vol. 2, pp. 700- 707 ,(2006) , 10.1038/NCPNEPH0344
Edmund G. Lowrie, Nancy L. Lew, Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between Facilities American Journal of Kidney Diseases. ,vol. 15, pp. 458- 482 ,(1990) , 10.1016/S0272-6386(12)70364-5
G. Dautin, Z. Soltani, D. Ducloux, T. Gautier, J.P. Pais de Barros, P. Gambert, L. Lagrost, D. Masson, Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase Kidney International. ,vol. 72, pp. 871- 878 ,(2007) , 10.1038/SJ.KI.5002449
Minoru Ando, Inger Lundkvist, Jonas Bergström, Bengt Lindholm, Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients Kidney International. ,vol. 49, pp. 773- 780 ,(1996) , 10.1038/KI.1996.107
, Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis The Lancet. ,vol. 371, pp. 117- 125 ,(2008) , 10.1016/S0140-6736(08)60104-X
Evi Trenkwalder, Karl Lhotta, Hans Dieplinger, Martin Auinger, Ulrich Neyer, Florian Kronenberg, Paul König, Thomas Meisl, Andreas Pribasnig, The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients A Prospective Follow-Up Journal of The American Society of Nephrology. ,vol. 10, pp. 1027- 1036 ,(1999) , 10.1681/ASN.V1051027
Gregory C. Shearer, George A. Kaysen, Proteinuria and Plasma Compositional Changes Contribute to Defective Lipoprotein Catabolism in the Nephrotic Syndrome by Separate Mechanisms American Journal of Kidney Diseases. ,vol. 37, ,(2001) , 10.1053/AJKD.2001.20766
Bjørn Egil Vikse, Lorentz M. Irgens, Torbjørn Leivestad, Stein Hallan, Bjarne M. Iversen, Low Birth Weight Increases Risk for End-Stage Renal Disease Journal of The American Society of Nephrology. ,vol. 19, pp. 151- 157 ,(2008) , 10.1681/ASN.2007020252